NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

NCT07146529

Not Yet RecruitingN/A

Sponsor: ANRS, Emerging Infectious Diseases

Conditions: HIV Seropositivity, HIV Drug Resistance, HIV Infections

The primary objective of the study is to determine the frequency of transmission of viruses carrying at least one antiretroviral resistance mutation in all participants newly diagnosed with HIV-1

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Participant (male or female) aged 18 years or older ;
* Participant newly diagnosed in the laboratory, for whom mandatory HIV seropositivity reporting to Santé Publique France (SPF) is required ;
* Participant naïve to all antiretroviral treatments (except PrEP and/or post-exposure prophylaxis \[PEP\]) ;
* Participant with an available HIV resistance genotype, including amplification of at least reverse transcriptase and protease ;
* Participant who has not objected to participating in the study.

Exclusion Criteria:

* Participant who objects to the use of their data ;
* Participant currently on antiretroviral treatment ;
* Participant subject to legal protection measures (safeguard of justice).